A joint presentation by an endocrinologist and ophthalmologist reviewed best practices for managing thyroid eye disease, ...

Topline data from Phase 2b/3 trial of izokibep as a treatment for non-infectious non-anterior uveitis expected in December 2024 Positive lonigutamab EOP2 FDA interaction completed and initiation of ...

H.C. Wainwright raised the firm’s price target on Viridian Therapeutics (VRDN) to $34 from $27 and keeps a Buy rating on the shares. The ...

China-based Minghui Pharmaceutical has linked its thyroid eye disease treatment to a reduction in eye bulging in a small phase 1b/2 clinical trial. The study enrolled 30 participants and assessed ...

Ocular autoimmune disease involves the immune system attacking the tissues of the eye. These diseases typically manifest through an autoantibody response targeting the retina, uvea, vitreous, and ...

If those aren’t enough, you may eventually need surgery. Treatment for thyroid eye disease is different from what you get for Graves’ disease. While getting your thyroid levels back to normal ...

Dry eye syndrome can significantly impact daily life and eye health. Excessive screen time and allergies aggravate this ...

A recent poll found that about 15.5 million Americans have used injectable diabetes medicines like Ozempic and Wegovy to lose ...